EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparison of antimicrobial resistance and serotype patterns in Streptococcus pneumoniae from blood cultures and respiratory specimens in Canadian hospitals from the CANWARD study (2007–23)

Heather J Adam iD, Alyssa R Golden iD, Irene Martin, Melanie R Baxter, Ross J Davidson, James A Karlowsky, George G Zhanel

Journal of Antimicrobial Chemotherapy · 2025

DOI: 10.1093/jac/dkaf219 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Heather J Adam und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Room 543-745 Bannatyne Avenue, Winn…. Hauptthemen laut MEDLINE: Streptococcus pneumoniae, Serogroup, Anti-Bacterial Agents, Pneumococcal Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: University of Manitoba, Shared Health, National Microbiology Laboratory.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To compare the antimicrobial resistance and serotype patterns in Streptococcus pneumoniae collected from blood cultures and respiratory specimens in Canada from 2007 to 2023.

Methods

S. pneumoniae isolates were submitted from Canadian hospitals as part of the ongoing national surveillance study, CANWARD. Antimicrobial susceptibility testing was performed by the CLSI broth microdilution method. Serotypes were determined using WGS and/or the Quellung method.

Results

Of the 3111 S. pneumoniae isolates collected, 1103 (35.5%) were from blood cultures and 2008 (64.5%) were from respiratory specimens. The most common serotypes overall were 3, 19A, 22F and 11A. Serotypes 4, 5, 7F, 8, 12F, 14, 19A and 22F were more frequently identified (P ≤ 0.01) among blood culture isolates, while 6C, 7C, 11A, 19F, 21, 23A, 23B, 23F, 31, 34, 35B, 35F and non-typeable strains were more commonly recognized (P ≤ 0.03) among respiratory isolates. Susceptibility rates were significantly lower in respiratory isolates than blood culture isolates for penicillin, ceftriaxone, clarithromycin, clindamycin and doxycycline (P ≤ 0.03). Overall, 8.3% of isolates were MDR/XDR; rates increased over the course of the study (P = 0.004). MDR/XDR rates were higher in respiratory isolates (10.5%) than in blood culture isolates (5.8%) (P < 0.0001). Serotypes 19A (40.6%) and 15A (27.6%) were predominant in the MDR/XDR isolates.

Conclusions

S. pneumoniae from respiratory specimens demonstrated lower antimicrobial susceptibilities and higher MDR rates compared with isolates from blood cultures. Significant differences in the serotypes isolated from blood culture and respiratory specimens were observed. A greater proportion of isolates from blood cultures were serotypes covered by current pneumococcal vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Streptococcus pneumoniaeSerogroupAnti-Bacterial AgentsPneumococcal InfectionsDrug Resistance, BacterialHumansCanadaMicrobial Sensitivity TestsBlood CultureHospitalsMaleMiddle AgedAdultAgedFemaleChild, PreschoolYoung AdultAdolescentChildInfantRespiratory SystemDrug Resistance, Multiple, Bacterial

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Room 543-745 Bannatyne Avenue, Winnipeg, Manitoba, Canada R3E 0J9.
  • Clinical Microbiology, Diagnostic Services, Shared Health, MS673-820 Sherbrook Street, Winnipeg, Manitoba, Canada R3A 1R9.
  • National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, Manitoba, Canada R3E 3M4.
  • Queen Elizabeth II Health Sciences Centre, Dalhousie University, 5788 University Avenue, Halifax, Nova Scotia, Canada B3H 1V8.

ORCID-Profile: Heather J Adam, Alyssa R Golden

Förderung

  • University of Manitoba
  • Shared Health
  • National Microbiology Laboratory
  • Avir Pharma Inc.
  • Iterum Therapeutics
  • Merck Canada Inc.
  • Paladin Labs
  • Pfizer

Zitieren

APA

Adam, H. J., Golden, A. R., Martin, I., Baxter, M. R., Davidson, R. J., Karlowsky, J. A., & Zhanel, G. G. (2025). Comparison of antimicrobial resistance and serotype patterns in Streptococcus pneumoniae from blood cultures and respiratory specimens in Canadian hospitals from the CANWARD study (2007–23). Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf219

Vancouver

Adam HJ, Golden AR, Martin I, Baxter MR, Davidson RJ, Karlowsky JA, et al. Comparison of antimicrobial resistance and serotype patterns in Streptococcus pneumoniae from blood cultures and respiratory specimens in Canadian hospitals from the CANWARD study (2007–23). Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf219

BibTeX
@article{Adam2025,
  author = {Adam, Heather J and Golden, Alyssa R and Martin, Irene and Baxter, Melanie R and Davidson, Ross J and Karlowsky, James A and Zhanel, George G},
  title = {Comparison of antimicrobial resistance and serotype patterns in Streptococcus pneumoniae from blood cultures and respiratory specimens in Canadian hospitals from the CANWARD study (2007–23)},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  doi = {10.1093/jac/dkaf219}
}
Kostenlos starten →